FDA app proves Pfizer drug to treat very rare lung disease
May 28, 2015 at 16:31 PM EDT
WASHINGTON, May 28 (Reuters) - The U.S. Food and Drug Administration on Thursday approved the first drug to treat a rare, progressive lung disease that mainly affects women of childbearing age.
